Wassila Rahali
Institut Gustave Roussy(FR)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Cancer Genomics and Diagnostics, CAR-T cell therapy research, Viral-associated cancers and disorders, Immune Cell Function and Interaction
Most-Cited Works
- → Sequence analyses of relapsed or refractory diffuse large B‐cell lymphomas unravel three genetic subgroups of patients and the GNA13 mutant as poor prognostic biomarker, results of LNH‐EP1 study(2023)4 cited
- → CAR T cell–mediated bone marrow inflammation causes hematotoxicity and favors clonal hematopoiesis(2025)2 cited
- → Molecular landscape of relapse/refractory diffuse large B‐cell lymphoma(2017)
- → FEASIBILITY AND BENEFIT OF MOLECULARLY‐INFORMED ENROLLMENT INTO EARLY PHASE CLINICAL TRIALS FOR PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA(2019)
- → Feasibility and Benefit of Molecularly-Informed Enrollment into Early Phase Clinical Trials for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma(2018)
- → Sequence Analyses of Relapsed or Refractory Diffuse Large B-Cell Lymphomas Unravels Three Genetic Subgroups of Patients and <i>GNA3</i> Mutant as Poor Prognosis Biomarker, Results of LNH-EP1 Study(2022)